Depressed with a chronic disease? Consider alternative therapies

November 6, 2017, UT Southwestern Medical Center
Dr. Madhukar Trivedi (front) is senior author of a JAMA study that adds to evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease. The findings raise a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans. Credit: UT Southwestern

Scientists are finding more evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.

A new study published in the Journal of the American Medical Association found depressed patients with did not benefit from a common antidepressant. The finding follows other research that indicates traditional antidepressants are also ineffective in depressed people with chronic conditions such as asthma and .

Experts with the O'Donnell Brain Institute say enough evidence now exists to prompt immediate change in how doctors approach cases in conjunction with chronic medical diseases.

"There is little justification in prescribing an antidepressant that will not work and will only cause side effects," says Dr. Madhukar Trivedi, senior author of the JAMA study and director of the Center for Depression Research and Clinical Care, part of the Peter O'Donnell Jr. Brain Institute at UT Southwestern Medical Center. "We should go back to the drawing board to understand the brain changes involved in these subtypes of depression."

Nearly half of Americans live with a , ranging from cancer and dementia to arthritis and asthma, according to the Centers for Disease Control and Prevention. Many of these people also have major depression, including more than half of Parkinson's patients, 41 percent of cancer patients, and more than a quarter of those with diabetes.

Doctors and patients should take these statistics into account when treating cases of , says Dr. Trivedi, Professor of Psychiatry and holder of the Betty Jo Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care.

He says both sides should understand that standard antidepressants may not work and be prepared to try alternatives if routine monitoring of symptoms and side effects show another strategy is needed.

Dr. Trivedi, who led the Star*D studies that established widely accepted treatment guidelines for depressed patients, has recently made progress on developing a blood test to determine in advance which antidepressants are more likely to work for important subgroups of patients. He also notes a range of other therapies that have proven effective for who don't respond to initial treatments. These include ketamine, electroconvulsive therapy, neuromodulation with magnetic stimulation, psychotherapy, and exercise.

Explore further: Blood test unlocks new frontier in treating depression

More information: S. Susan Hedayati et al. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence, JAMA (2017). DOI: 10.1001/jama.2017.17131

Related Stories

Blood test unlocks new frontier in treating depression

March 29, 2017
Doctors for the first time can determine which medication is more likely to help a patient overcome depression, according to research that pushes the medical field beyond what has essentially been a guessing game of prescribing ...

Work productivity is key factor in assessing recovery of depressed patients

August 15, 2016
While medications can quickly reduce depressive symptoms, monitoring work productivity can provide unique insight into whether a patient will require additional treatments to achieve long-term remission, a new study through ...

Antidepressants associated with significantly elevated risk of death, researchers find

September 14, 2017
Antidepressant medications, most commonly prescribed to reduce depression and anxiety, increase the risk of death, according to new findings by a McMaster-led team of researchers.

Study answers why ketamine helps depression, offers target for safer therapy

June 21, 2017
UT Southwestern Medical Center scientists have identified a key protein that helps trigger ketamine's rapid antidepressant effects in the brain, a crucial step to developing alternative treatments to the controversial drug ...

Brief depression questionnaires could lead to unnecessary antidepressant prescriptions

September 29, 2014
Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published ...

Recommended for you

Study: Tinder loving cheaters—dating app facilitates infidelity

February 23, 2018
The popular dating app Tinder is all about helping people form new relationships. But for many college-aged people, it's also helping those in relationships cheat on their romantic partners.

The 'loudness' of our thoughts affects how we judge external sounds

February 23, 2018
The "loudness" of our thoughts—or how we imagine saying something—influences how we judge the loudness of real, external sounds, a team of researchers from NYU Shanghai and NYU has found.

Looking for the origins of schizophrenia

February 23, 2018
Schizophrenia may be related to neurodevelopmental changes, including brain's inability to generate an appropriate vascular system, according to new study resulted from a partnership between the D"Or Institute for Research ...

Color of judo uniform has no effect on winning

February 22, 2018
New research on competitive judo data finds a winning bias for the athlete who is first called, regardless of the colour of their uniform. This unique study, published in Frontiers in Psychology, puts to rest the debate on ...

Infants are able to learn abstract rules visually

February 22, 2018
Three-month-old babies cannot sit up or roll over, yet they are already capable of learning patterns from simply looking at the world around them, according to a recent Northwestern University study published in PLOS One.

Antidepressants are more effective than placebo at treating acute depression in adults, concludes study

February 22, 2018
Meta-analysis of 522 trials includes the largest amount of unpublished data to date, and finds that antidepressants are more effective than placebo for short-term treatment of acute depression in adults.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.